V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10408909 | 10041103 | 1.86 | 66.6 | Disease modification (D) | 2018-06-02 | 2018-07-03 | R GCVP | 02 | null | BCG | 101262958 |
| 10408967 | 10041104 | null | 69 | null | 2018-09-11 | 2018-09-12 | CISPLATIN + FLUOROURACIL + RT | 02 | Y | CAPECITABINE + CISPLATIN | 100864006 |
| 10409106 | 10041107 | 1.63 | 94 | Palliative (P) | 2018-03-25 | 2018-03-29 | Bortezomib (weekly) | 02 | N | BORTEZOMIB | 101651986 |
| 10409130 | 10041108 | null | 80 | Disease modification (D) | 2016-09-06 | 2016-10-05 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 02 | N | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 100189922 |
| 10409187 | 10041109 | 1.66 | 91 | 03 | 2017-10-17 | 2017-10-29 | BCG Intravesical | 02 | null | TRIAL | 100324122 |
| 10409217 | 10041110 | 1.72 | 67 | Palliative (P) | 2016-11-29 | 2016-12-06 | Mitomycin Intravesical | 02 | N | MITOMYCIN INTRAVESICULAR | 101473163 |
| 10409310 | 10041112 | 1.75 | 59 | Adjuvant (A) | 2019-06-14 | 2019-06-23 | CHOP R - 21 days | 02 | N | CHOP R | 101022305 |
| 10409363 | 10041113 | 1.7 | 104 | Disease modification (D) | 2019-06-15 | 2019-06-29 | Irinotecan + Modified De Gramont | 02 | N | FLUOROURACIL + IRINOTECAN | 101422272 |
| 10409462 | 10041114 | 0 | 0 | 03 | 2018-08-06 | 2018-08-12 | CISPLATIN + VINORELBINE + RT | null | N | CISPLATIN + VINORELBINE | 100141381 |
| 10409627 | 10041118 | 1.73 | 96.3 | null | 2018-05-07 | 2018-07-02 | FLUOROURACIL + IRINOTECAN | 02 | null | FLUOROURACIL + IRINOTECAN | 100065357 |
| 10409639 | 10041119 | 1.8 | 88.8 | Adjuvant (A) | 2016-03-03 | 2016-03-03 | Cyclophosphamide + Docetaxel | 02 | N | POMALIDOMIDE | 101660794 |
| 10409698 | 10041120 | 1.65 | 79.6 | Curative (C) | 2017-11-03 | 2017-11-12 | BUSULFAN | 02 | Y | CISPLATIN + VINORELBINE | 101157500 |
| 10409892 | 10041123 | 1.57 | 85.5 | Palliative (P) | 2022-04-24 | 2022-05-20 | CAPECITABINE + GEMCITABINE | 02 | N | POMALIDOMIDE | 101628747 |
| 10409940 | 10041124 | 0 | 0 | Palliative (P) | 2018-03-20 | 2018-04-08 | Venetoclax | 02 | N | TRIAL | 101609885 |
| 10410025 | 10041126 | null | 85.25 | Palliative (P) | 2019-05-05 | 2019-05-22 | Acalabrutinib | 02 | null | ACALABRUTINIB | 101209874 |
| 10410076 | 10041127 | 1.54 | 47 | Palliative (P) | 2019-10-20 | 2019-11-06 | CYCLOPHOSPHAMIDE + RITUXIMAB + Dexamethasone | 02 | N | CISPLATIN + VINORELBINE | 101134847 |
| 10410164 | 10041128 | 0 | 89.9 | Curative (C) | null | 2018-01-05 | TEMOZOLOMIDE | 02 | N | TEMOZOLOMIDE | 100279961 |
| 10410241 | 10041130 | 1.76 | 103 | 03 | 2018-08-08 | 2018-08-19 | DARATUMUMAB | 02 | N | CISPLATIN + VINORELBINE | 100607216 |
| 10410368 | 10041131 | 1.73 | 73.4 | Adjuvant (A) | 2017-01-07 | 2017-01-20 | Cytarabine Low Dose | 02 | N | CYCLOPHOSPHAMIDE + RITUXIMAB | 100153451 |
| 10410404 | 10041132 | 1.63 | 78.4 | null | 2021-04-24 | 2021-04-24 | CVP R | 02 | null | VENETOCLAX | 101660431 |
| 10410422 | 10041133 | 1.7 | 94.3 | null | 2020-04-04 | 2020-04-10 | Trial Unspecified | 02 | N | MITOMYCIN | 101161472 |
| 10410544 | 10041134 | 1.8 | 79.7 | Curative (C) | 2019-07-20 | 2019-07-31 | Bortezomib +/- Dexamethasone | null | null | BORTEZOMIB | 101709976 |
| 10410612 | 10041135 | 1.8 | 78.4 | Palliative (P) | 2019-06-03 | 2019-06-03 | BCG Intravesical | 02 | N | POMALIDOMIDE | 101686065 |
| 10410651 | 10041136 | 0 | 0 | 03 | 2018-06-17 | 2018-07-12 | Temozolomide + RT | 02 | N | TEMOZOLOMIDE | 101423687 |
| 10410684 | 10041137 | 1.77 | 90 | Curative (C) | 2018-03-02 | 2018-03-06 | Carboplatin + Pembrolizumab + Pemetrexed | N | N | DABRAFENIB + TRAMETINIB | 100401278 |
| 10410765 | 10041138 | 0 | 60 | null | 2018-08-29 | 2018-09-15 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 02 | null | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 100192420 |
| 10410827 | 10041139 | 1.77 | 85.8 | Palliative (P) | 2019-07-27 | 2019-07-27 | BORTEZOMIB + THALIDOMIDE | 02 | Y | BORTEZOMIB + THALIDOMIDE | 101432799 |
| 10410840 | 10041140 | 0 | 0 | Adjuvant (A) | 2017-09-15 | 2017-09-22 | CYCLOPHOSPHAMIDE + THALIDOMIDE | null | null | PAZOPANIB | 100727709 |
| 10410951 | 10041142 | 1.62 | 49.3 | null | 2019-08-01 | 2019-08-18 | FLUOROURACIL + IRINOTECAN | N | null | FLUOROURACIL + IRINOTECAN | 100557383 |
| 10410967 | 10041143 | 1.78 | null | Neo-adjuvant (N) | 2015-12-23 | 2015-12-25 | Cladribine (subcut) 5 days | 02 | N | SUNITINIB | 101676702 |
| 10411042 | 10041146 | 1.68 | 69.8 | Palliative (P) | 2018-09-04 | 2018-09-05 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 101059147 |
| 10411272 | 10041147 | 1.62 | 57.6 | Adjuvant (A) | 2019-06-23 | 2019-07-05 | CYTARABINE | 02 | N | CYCLOPHOSPHAMIDE + RITUXIMAB | 101105678 |
| 10411344 | 10041148 | 0 | 0 | Curative (C) | 2019-07-04 | 2019-07-12 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | N | Y | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 101332368 |
| 10411532 | 10041151 | 0 | 0 | Curative (C) | 2021-01-05 | 2021-02-01 | DARATUMUMAB | 02 | null | BUSULFAN | 101519758 |
| 10411591 | 10041152 | 1.77 | 64 | null | 2017-01-13 | 2017-01-13 | Chlorambucil + Pred + Rituximab | 02 | null | CHLORAMBUCIL + RITUXIMAB | 101459752 |
| 10411661 | 10041154 | 1.53 | 83 | Adjuvant (A) | 2017-10-23 | 2017-11-06 | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE | 02 | Y | CYTARABINE | 101728243 |
| 10411732 | 10041155 | 1.62 | 80 | Neo-adjuvant (N) | 2018-05-12 | 2018-05-16 | MITOMYCIN | 02 | N | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE | 100791723 |
| 10411812 | 10041156 | 1.81 | 92 | Palliative (P) | 2019-03-22 | 2019-03-24 | CHOP - 21 days | N | N | CISPLATIN + FLUOROURACIL | 101117715 |
| 10411899 | 10041158 | 1.7 | 95 | Neo-adjuvant (N) | null | 2018-05-20 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100710407 |
| 10411976 | 10041159 | 1.67 | 94 | null | null | 2018-08-05 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 02 | null | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 101809948 |
| 10411984 | 10041160 | 1.77 | 80.8 | Adjuvant (A) | 2016-09-22 | 2016-10-01 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101140401 |
| 10411991 | 10041161 | null | 84.1 | Curative (C) | 2021-08-18 | 2021-09-16 | CHOP | 02 | null | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 101382412 |
| 10412003 | 10041162 | 1.91 | 79 | 03 | 2019-09-24 | 2019-09-24 | Palbociclib | N | N | PALBOCICLIB | 100384497 |
| 10412053 | 10041163 | 1.78 | 48 | Disease modification (D) | null | 2019-10-04 | Bortezomib +/- Dexamethasone | 02 | N | BORTEZOMIB | 101311164 |
| 10412169 | 10041165 | 1.84 | 55.9 | 03 | 2017-11-26 | 2017-11-26 | Bortezomib (weekly) | 02 | null | BORTEZOMIB | 101186487 |
| 10412181 | 10041166 | 1.8 | 53 | null | 2022-02-04 | 2022-02-04 | BCG Intravesical | N | null | VENETOCLAX | 101779856 |
| 10412204 | 10041167 | 1.67 | 65 | Adjuvant (A) | 2020-04-17 | 2020-04-20 | DARATUMUMAB | 99 | N | CLADRIBINE | 100986138 |
| 10412273 | 10041171 | 1.85 | 77.15 | null | 2020-05-04 | 2020-05-16 | Gemcitabine + Capecitabine | 02 | null | PAZOPANIB | 100231799 |
| 10412285 | 10041172 | 1.68 | 69.9 | Neo-adjuvant (N) | 2019-12-04 | 2019-12-17 | Carboplatin + Vinorelbine Oral | 02 | null | CARBOPLATIN + VINORELBINE | 100030927 |
| 10412316 | 10041173 | 1.77 | 113.5 | Palliative (P) | null | 2021-11-16 | FEC + DOCETAXEL | 02 | N | MITOMYCIN | 100428433 |